IM Cannabis (IMCC) EPS (Weighted Average and Diluted) (2020 - 2025)

IM Cannabis' EPS (Weighted Average and Diluted) history runs 6 years deep, the most recent figure standing at $0.54 for Q3 2025.

• In Q3 2025, EPS (Weighted Average and Diluted) rose 281.33% year-over-year to $0.54; the TTM figure through Sep 2025 stood at $201.08 (up 101.65% YoY), while the FY2024 annual figure was -$3.29, changed 0.12% from the prior year.
• EPS (Weighted Average and Diluted) was $0.54 for Q3 2025 at IM Cannabis, up from -$17.8 million in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $78.6 million in Q1 2021 to a low of -$41.4 million in Q2 2022.
• Historically, EPS (Weighted Average and Diluted) has averaged -$4.1 million across 5 years, with a median of -$2.0 million in 2022.
• The sharpest annual moves came in 2023 and 2025: EPS (Weighted Average and Diluted) plunged 2488.83% in 2023, then soared 281.33% in 2025.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$36.0 million in 2021, then jumped by 99.59% to -$147010.1 in 2022, then slumped by 2488.83% to -$3.8 million in 2023, then soared by 100.0% to -$6.3 in 2024, then surged by 108.65% to $0.54 in 2025.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.54 (Q3 2025), -$17.8 million (Q2 2025), and -$6.3 (Q4 2024), per Business Quant data.